Previous studies had illustrated the proportion of de novo mutations in OI with COL1A1/COL1A2 mutations: 41.03% in South Korea (13), 56.16% in Estonia, Ukraine, and Vietnam (14), and 54.6% in our previous report (15). The gene discussed is COL1A2; the disease is osteogenesis imperfecta.